Pinned Tweet
🪔 Diwali 2026 – My Top 5 Stock Picks to Watch! 📈
Five stocks on my watchlist with significant potential:
Satin Creditcare – CMP: ₹260
Dhanlaxmi Bank – CMP: ₹33
ELGi Equipments – CMP: ₹560
Lumax Auto Technologies – CMP: ₹2,327
Force Motors – CMP: ₹19,000
🚨 US STOCK MARKET BLOODBATH
Nearly $1 trillion reportedly wiped out in a single session.
AI and semiconductor stocks are getting hammered as investors question whether the AI boom can justify today’s sky-high valuations.
Is the tide turning?
1/6
1
39
🤖 WHY IS THE MARKET SELLING OFF?
🔹 Stretched AI valuations
🔹 Massive data centre spending
🔹 Profit-booking in semiconductors
🔹 Questions over future AI earnings
🔹 Rising risk aversion
Are investors finally questioning the AI investment narrative?
5/6
1
6
JAYBARMARU is looking good, can give good return in medium term. Accumulate in dips and hold until next result.
Ok thanks bye
1
91
SIGACHI up 10% today
👀 Sigachi Industries is an interesting name to watch!
The story could unfold positively over the medium term. One to keep on the radar as the business developments and financial performance play out. 📊📈
#SigachiIndustries #IndianMarkets
1
130
TD POWER SYSTEMS: CO RAISES FY27 REVENUE GUIDANCE TO ₹2,900-3,000 CRORE, SETS FY28 TARGET OF ₹3,400-3,500 CRORE; SEES POTENTIAL FOR $1 BILLION REVENUE IN MEDIUM TERM
I added #TDPOWER when it fell 15% amid anti-AI sentiment after Democrats took the House. I had held it earlier and regretted exiting.
The lesson? You don’t always have to trade. Keep cash ready, identify quality names and wait for the right price. Patience and timing build wealth
1
208
KWIL up 7% today
Keep an eye on Kwality Walls (#KWIL). Looks poised for a move towards ₹50+. Do your own research before making any investment decision. Not a buy or sell recommendation.
105
💊 PANACEA BIOTEC | CMP ₹358
👀 An interesting stock to keep on the radar!
The September 2026 quarter shows a meaningful improvement in revenue, margins and profitability. Is this the beginning of a sustainable turnaround? Let’s look at the numbers. 🧵 (1/8)
1
162
🔍 WHAT MATTERS NEXT?
At ₹358, I would closely monitor:
✅ Sustained revenue growth
✅ Margin expansion
✅ Vaccine segment recovery
✅ Operating cash flows
✅ Working capital and balance sheet strength
Consistency is key! 🎯 (7/8)
1
35













